Molluscum contagiosum
Molluscum contagiosum | |
---|---|
Other names | Water warts |
laser therapy[7] | |
Medication | Cimetidine, podophyllotoxin[7] |
Frequency | 122 million / 1.8% (2010)[8] |
Molluscum contagiosum (MC), sometimes called water warts, is a
The infection is caused by a
Prevention includes
Approximately 122 million people globally were affected by molluscum contagiosum as of 2010 (1.8% of the population).[8] It is more common in children between the ages of one and ten years old.[2] The condition has become more common in the United States since 1966.[2] But having an infection is not a reason to keep a child out of school or daycare.[10]
Signs and symptoms
Molluscum contagiosum lesions are flesh-colored, dome-shaped, and pearly in appearance. They are often 1–5 mm in diameter, with a dimpled center.
Individual molluscum lesions may go away on their own within two months and generally clear completely without treatment or scarring in six to twelve months.
Transmission
As the name implies, molluscum contagiosum is extremely contagious.[3] Transmission of the molluscum contagiosum virus can occur many different ways including direct skin contact (e.g., contact sports or sexual activity), contact with an infected surface (fomite), or autoinoculation (self-infection) by scratching or picking molluscum lesions and then touching other parts of the skin not previously affected by the virus.[3] Children are particularly susceptible to autoinoculation and may have widespread clusters of lesions.[17]
The viral infection is limited to a localized area on the topmost layer of the superficial layer of the skin.[18] Once the virus-containing head of the lesion has been destroyed, the infection is gone. The central waxy core contains the virus.[citation needed]
Diagnosis
Diagnosis is made on the appearance; the virus cannot routinely be cultured. The diagnosis can be confirmed by excisional biopsy.[citation needed]
Histologically, molluscum contagiosum is characterized by molluscum bodies (also known as Henderson-Patterson bodies) in the
-
Low magnification micrograph of a molluscum contagiosum lesion
-
Low-magnification micrograph of molluscum contagiosum, H&E stain
-
High-magnification micrograph of molluscum contagiosum, showing the characteristic molluscum bodies, H&E stain
Management
Because molluscum contagiosum usually resolves without treatment and treatment options can cause discomfort to children, initial recommendations are often to simply wait for the lesions to resolve on their own.[21] Of the treatments available, a meta-analysis of randomized controlled trials suggested that there is no difference between treatments in short term improvement, and no single treatment is significantly better than natural resolution of the condition.[22]
Bumps located in the genital area may be treated in an effort to prevent them from spreading.[16] When treatment has resulted in the elimination of all bumps, the infection has been effectively cured and will not reappear unless the person is reinfected.[23]
Medications
For mild cases,
Studies have found cantharidin to be an effective and safe treatment for removing molluscum contagiosum.[25] This medication is usually well tolerated though mild side effects such as pain or blistering are common.[25] There is no high-quality evidence for cimetidine.[26] However, oral cimetidine has been used as an alternative treatment for the pediatric population as it is generally well tolerated and less invasive.[27]
Berdazimer sodium
Imiquimod
- Potential adverse effects of imiquimod use: "Similar to the studies conducted in adults, the most frequently reported adverse reaction from 2 studies in children with molluscum contagiosum was application site reaction. Adverse events which occurred more frequently in Aldara-treated subjects compared with vehicle-treated subjects generally resembled those seen in studies in indications approved for adults and also included otitis media (5% Aldara vs. 3% vehicle) and conjunctivitis (3% Aldara vs. 2% vehicle). Erythema was the most frequently reported local skin reaction. Severe local skin reactions reported by Aldara-treated subjects in the pediatric studies included erythema (28%), edema (8%), scabbing/crusting (5%), flaking/scaling (5%), erosion (2%) and weeping/exudate (2%)."[citation needed]
- Potential systemic absorption of imiquimod, with negative effects on white blood cell counts overall, and specifically neutrophil counts: "Among the 20 subjects with evaluable laboratory assessments, the median WBC count decreased by 1.4*109/L and the median absolute neutrophil count decreased by 1.42×109 L−1."[36]
Surgery
Surgical treatments include cryosurgery, in which liquid nitrogen is used to freeze and destroy lesions, as well as scraping them off with a curette. Application of liquid nitrogen may cause burning or stinging at the treated site, which may persist for a few minutes after the treatment. With liquid nitrogen, a blister may form at the treatment site, but it will slough off in two to four weeks. Cryosurgery and curette scraping can be painful procedures and can result in residual scarring.[37]
Laser
A 2014 systematic review of
Prognosis
Most cases of molluscum contagiosum will clear up naturally within two years (usually within nine months). So long as the skin growths are present, there is a possibility of transmitting the infection to another person. When the growths are gone, the possibility of spreading the infection is ended.[23]
Unlike
Epidemiology
As of 2010, approximately 122 million people were affected worldwide by molluscum contagiosum (1.8% of the population).[8]
See also
- Acrochordons(also called skin tags—similar in appearance and grow in similar areas)
- Basal-cell carcinoma
- human papillomavirus; also similar in appearance to molluscum)
References
- ^ a b c d e f g "Molluscum Contagiosum". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2015. Archived from the original on 16 June 2017. Retrieved 10 June 2017.
- ^ a b c d e "Risk Factors | Molluscum Contagiosum". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2015. Archived from the original on 10 June 2017. Retrieved 10 June 2017.
- ^ PMID 26612372.
- ^ a b c "Transmission | Molluscum Contagiosum". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2015. Archived from the original on 10 June 2017. Retrieved 10 June 2017.
- ISBN 978-0323076999.
- ^ a b "Prevention | Molluscum Contagiosum". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2015. Archived from the original on 17 June 2017. Retrieved 10 June 2017.
- ^ a b c d e "Treatment Options | Molluscum Contagiosum". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2015. Archived from the original on 17 June 2017. Retrieved 10 June 2017.
- ^ PMID 23245607.
- ^ a b "Long Term Effects | Molluscum Contagiosum". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2015. Archived from the original on 17 June 2017. Retrieved 10 June 2017.
- ^ "Day Care Centers and Schools | Molluscum Contagiosum". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2015. Archived from the original on 17 June 2017. Retrieved 10 June 2017.
- PMID 21771922.
- PMID 24559566.
- ^ "Molluscum contagiosum | DermNet NZ". dermnetnz.org. Retrieved 2021-07-30.
- PMID 10591712.
- ^ MedlinePlus Encyclopedia: Molluscum Contagiosum
- ^ PMID 14532898.
- ^ "Molluscum Contagiosum". The Lecturio Medical Concept Library. Retrieved 11 August 2021.
- ^ "Pamphlets: Molluscum Contagiosum". American Academy of Dermatology. 2006. Archived from the original on 2008-12-01. Retrieved 2008-11-30.
- PMID 23972567.
- PMID 23798852.
- ^ Prodigy knowledgebase (July 2003). "Molluscum Contagiosum". National Health Service. Archived from the original on 2010-10-13. Retrieved 2010-04-20.
- PMID 28513067.
- ^ a b c "Frequently Asked Questions: For Everyone. CDC Molluscum Contagiosum". United States Centers for Disease Control and Prevention. Archived from the original on 2008-12-19. Retrieved 2008-12-08.
- PMID 28513067.
- ^ from the original on 2016-03-04.
- from the original on 2008-09-28.
- ^ "Treatment Options - Molluscum Contagiosum - Pox viruses - CDC". U.S. Centers for Disease Control and Prevention (CDC). 2 October 2017.
- ^ a b "Zelsuvmi (berdazimer) topical gel" (PDF). Archived (PDF) from the original on 19 January 2024. Retrieved 9 January 2024.
- ^ "GSRS". gsrs.ncats.nih.gov. Archived from the original on 8 January 2024. Retrieved 8 January 2024.
- ^ "Drug Approval Package: Zelsuvmi". U.S. Food and Drug Administration (FDA). 2 February 2024. Archived from the original on 11 March 2024. Retrieved 11 March 2024.
- ^ "Novel Drug Approvals for 2024". U.S. Food and Drug Administration (FDA). 5 January 2024. Archived from the original on 8 January 2024. Retrieved 8 January 2024.
- ^ "U.S. Food and Drug Administration Approves Zelsuvmi as a First-in-Class Medication for the Treatment of Molluscum Contagiosum". Ligand Pharmaceuticals. 5 January 2024. Archived from the original on 8 January 2024. Retrieved 8 January 2024 – via Business Wire.
- S2CID 43224667.
- ^ PMID 25587702.
- S2CID 29556501.
- ^ DailyMed. Aldara (imiquimod) Cream for Topical use (Prescribing information): "DailyMed". Archived from the original on 2013-07-16. Retrieved 2013-07-17.
- ^ PMID 25607701.
- PMID 19835348.